HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasuhiro Kawamoto Selected Research

14-3-3 Proteins (14-3-3 Protein)

1/2011Colocalization of 14-3-3 proteins with SOD1 in Lewy body-like hyaline inclusions in familial amyotrophic lateral sclerosis cases and the animal model.
3/2006Upregulated expression of 14-3-3 proteins in astrocytes from human cerebrovascular ischemic lesions.
8/200514-3-3 proteins in Lewy body-like hyaline inclusions in a patient with familial amyotrophic lateral sclerosis with a two-base pair deletion in the Cu/Zn superoxide dismutase (SOD1) gene.
12/200414-3-3 proteins in Lewy body-like hyaline inclusions in patients with sporadic amyotrophic lateral sclerosis.
10/2004Enhanced expression of 14-3-3 proteins in reactive astrocytes in Creutzfeldt-Jakob disease brains.
2/2004Increased 14-3-3 immunoreactivity in glial elements in patients with multiple sclerosis.
12/2002Accumulation of 14-3-3 proteins in glial cytoplasmic inclusions in multiple system atrophy.
3/200214-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yasuhiro Kawamoto Research Topics

Disease

6Multiple System Atrophy
01/2018 - 12/2002
5Parkinson Disease (Parkinson's Disease)
07/2014 - 03/2002
3Dementia (Dementias)
07/2014 - 10/2008
3Alzheimer Disease (Alzheimer's Disease)
02/2012 - 10/2004
3Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2011 - 12/2004
1Parkinson Disease 13
08/2020
1Amyloid Plaque
12/2010
1Epilepsia Partialis Continua
06/2009
1Neurodegenerative Diseases (Neurodegenerative Disease)
10/2008
1Synucleinopathies
10/2008
1Intracranial Thrombosis (Cerebral Thrombosis)
03/2006
1Lacunar Stroke
03/2006
1Brain Ischemia (Cerebral Ischemia)
03/2006
1Gliosis
03/2006
1Intracranial Embolism
03/2006
1Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
03/2006
1Acquired CJD
10/2004
1Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease)
10/2004
1Cerebral Hemorrhage
06/2004
1Infarction (Infarctions)
06/2004
1Glioma (Gliomas)
05/2004
1Multiple Sclerosis
02/2004
1Progressive Multifocal Leukoencephalopathy
02/2004
1Lewy Body Disease (Lewy Body Dementia)
03/2002

Drug/Important Bio-Agent (IBA)

814-3-3 Proteins (14-3-3 Protein)IBA
01/2011 - 03/2002
6ParaffinIBA
01/2016 - 03/2006
6Formaldehyde (Formol)FDA Link
01/2016 - 03/2006
5Proteins (Proteins, Gene)FDA Link
08/2020 - 06/2004
4alpha-SynucleinIBA
10/2008 - 05/2004
2Apoptosomes (Apoptosome)IBA
01/2016 - 07/2014
2Superoxide Dismutase-1IBA
01/2011 - 08/2005
2Peptides (Polypeptides)IBA
12/2010 - 06/2004
2Amyloid (Amyloid Fibrils)IBA
12/2010 - 06/2004
1PresenilinsIBA
08/2020
1SynucleinsIBA
01/2018
1Caspase 9IBA
01/2016
1Serine Proteases (Serine Protease)IBA
12/2010
1Flumazenil (Romazicon)FDA LinkGeneric
06/2009
1Heat-Shock Proteins (Heat-Shock Protein)IBA
03/2006
1Brain-Derived Neurotrophic Factor (BDNF)IBA
05/2004
1EnzymesIBA
05/2004
1Nerve Growth Factors (Neurotrophins)IBA
05/2004
1ImmunosorbentsIBA
05/2004